Nanosonotechnology: The next challenge in cancer sonodynamic therapy

Nanotechnology Reviews

Volumn 1, Issue 2, 2012, Pages 173-182

  Serpe, Loredana ^a   Foglietta, Federica ^a   Canaparo, Roberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cancer; Nanoparticles; Sonodynamic therapy; Sonosensitizers; Ultrasound

Indexed keywords

CYTOTOXICITY; DISEASES; ENERGY TRANSFER; NANOPARTICLES; NANOTECHNOLOGY; ULTRASONICS;

ACOUSTIC CAVITATIONS; ANTICANCER TREATMENT; CANCER; CHEMICAL MECHANISM; NON THERMAL EFFECT; PHOTODYNAMIC THERAPY (PDT); SONODYNAMIC THERAPY; SONOSENSITIZERS;

PHOTODYNAMIC THERAPY;

EID: 84877101130     PISSN: 21919089     EISSN: 21919097     Source Type: Journal    
DOI: 10.1515/ntrev-2011-0009     Document Type: Article

References (77)

1. Leighton TG. What is ultrasound ? Prog. Biophys. Mol. Biol. 2007, 93, 3-83.
2. Maderbbacher S, Marberger M. High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J. Endourol. 2003, 17, 667-672.
3. Park K. Nanotechnology: what it can do for drug delivery. J. Control. Release 2007, 120, 1-3.
4. Suslick KS. Sonochemistry. Science 1990, 247, 1439-1445.
5. Suslick KS, Doktycz SJ, Flint EB. On the origin of sonoluminescence and sonochemistry Ultrasonics 1990, 28, 280-290.
6. Didenko YT, Suslick KS. The energy efficiency of formation of photons, radicals and ions during single-bubble cavitation. Nature 2002, 418, 394-396.
7. Tachibana K, Tachibana S. The use of ultrasound for drug delivery. Echocardiography 2001, 18, 323-328.
8. Tachibana K, Feril Jr L, Ikeda-Dantsuji Y. Sonodynamic therapy. Ultrasonics 2008, 48, 253-259.
9. Tachibana K, Tachibana S. Application of ultrasound energy as a new drug delivery system. Jpn. J. Appl. Phys. 1999, 38, 3014-3019.
10. Siegel RJ, Atar S, Fishbein MC, Brasch AV, Peterson TM, Nagai T, Pal D, Nishioka T, Chae JS, Birnbaum Y, Zanelli C, Luo H. Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries. Echocardiography 2001, 18, 247-257.
11. Huber PE, Mann MJ, Melo LG, Ehsan A, Kong D, Zhang L, Rezvani M, Peschke P, Jolesz F, Dzau VJ, Hynynen K. Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Ther. 2003, 10, 1600-1607.
12. Umemura S, Yumita N, Nishigaki R, Umemura K. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn. J. Cancer Res. 1990, 81, 962-966.
13. Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, Nishigaki R. Recent advances in sonodynamic approach to cancer therapy. Ultrason. Sonochem. 1996, 3, S187-S191.
14. Yu T, Wang Z, Mason TJ. A review of research into the uses of low level ultrasound in cancer therapy. Ultrason. Sonochem. 2004, 11, 95-103.
15. Shivastava SK, Kailash. Shock wave treatment in medicine. J. Biosci. 2005, 30, 269-275.
16. Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 2004, 11, 349-363.
17. Ahmed HU, Zacharakis E, Dudderidge T, Armitage JN, Scott R, Calleary J, Illing R, Kirkham A, Freeman A, Ogden C, Allen C, Emberton M. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br. J. Cancer 2009, 101, 19-26.
18. Adinno MA, Al-Karmis AM, Stoltz PA, Matthews JC, Crum LA. Effect of free radical scavengers on changes in ion conductance during exposure to therapeutic ultrasound. Membr. Biochem. 1993, 10, 237-247.
19. Canaparo R, Serpe L, Catalano MG, Bosco O, Zara GP, Berta L, Frairia R. High energy shock waves (HESW) for sonodynamic therapy: effects on HT-29 human colon cancer cells. Anticancer Res. 2006, 26, 3337-3342.
20. Serpe L, Canaparo R, Berta L, Bargoni A, Zara GP, Frairia R. High energy shock waves and 5-aminolevulinic for sonodynamic therapy: effects in a syngeneic model of colon cancer. Technol. Cancer Res. Treat. 2011, 10, 85-93.
21. Yumita N, Okuyama N, Sasaki K, Umemura S. Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium-porphyrin complex ATX-70. Cancer Chemother. Pharmacol. 2007, 60, 891-897.
22. Kuroki M, Hachimine K, Abe H, Shibaguchi H, Kuroki M, Maekawa S, Yanagisawa J, Kinugasa T, Tanaka T, Yamashita Y. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res. 2007, 27, 3673-3677.
23. Shi H, Liu Q, Qin X, Wang P, Wang X. Pharmacokinetic study of a novel sonosensitizer chlorin-e6 and its sonodynamic anticancer activity in hepatoma-22 tumor-bearing mice. Biopharm. Drug Dispos. 2011, 32, 319-332.
24. Zhu B, Liu Q, Wang Y, Wang X, Wang P, Zhang L, Su S. Comparison of accumulation, subcellular location, and sonodynamic cytotoxicity between hematoporphyrin and protoporphyrin IX in L1210 cells. Chemotherapy 2010, 56, 403-410.
25. Yumita N, Umemura S. Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour. J. Pharm. Pharmacol. 2004, 56, 85-90.
26. Lewis TJ. Toxicity and cytopathogenic properties toward human melanoma cells of activated cancer therapeutics in zebra fish. Integr. Cancer Ther. 2010, 9, 84-92.
27. Meng Y, Zou C, Madiyalakan R, Woo T, Huang M, Yang X, Swanson E, Che J, Xing JZ. Water-soluble and biocompatible sono/photosensitizer nanoparticles for enhanced cancer therapy. Nanomedicine 2010, 5, 1559-1569.
28. el Sharabasy MM, el Waseef AM, Hafez MM, Salim SA. Porphyrin metabolism in some malignant diseases. Br. J. Cancer 1992, 65, 409-412.
29. Frank J, Lambert C, Biesalski HK, Thews O, Vaupel P, Kelleher DK. Intensified oxidative and nitrosative stress following combined ALA-based photodynamic therapy and local hypertermia in rat tumors. Int. J. Cancer 2003, 107, 941-948.
30. Yang SJ, Shieh MJ, Lin FH, Lou PJ, Peng CL, Wei MF, Yao CJ, Lai PS, Young TH. Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nanoparticles. Cancer Lett. 2009, 273, 210-220.
31. Husseini GA, Diaz de la Rosa MA, Richardson ES, Christensen DA, Pitt WG. The Role of cavitation in acoustically activated drug delivery. J. Control. Release 2005, 107, 253-261.
32. Husseini GA, Christensen DA, Rapoport NY, Pitt WG. Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,Ndiethylacrylamide. J. Control. Release 2002, 83, 302-304.
33. Husseini GA, El-Fayoumi RI, O'Neill KL, Rapoport NY, Pitt WG. DNA damage induced by micellar delivered doxorubicin and ultrasound: comet assay study. Cancer Lett. 2000, 154, 211-216.
34. Nelson JL, Roeder BL, Carmen JC, Roloff F, Pitt WG. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res. 2002, 62, 7280-7283.
35. Hill CR. Ultrasonic Exposure Thresholds for Changes in Cells and Tissues. J. Acoust. Soc. Am. 1971, 52, 667-672.
36. Kuijpers MWA, van Eck D, Kemmere MF, Keurentjes JTF. Cavitation-induced reactions in high pressure carbon dioxide. Science 2002, 298, 1969-1971.
37. Flynn HG, Church CC. Transient pulsations of small gas bubbles in water. J. Acoust. Soc. Am. 1988, 84, 1863-1876.
38. Barnett S. Thresholds for nonthermal bioeffects: theoretical and experimental basis for a threshold index. Ultrasound Med. Biol. 1998, 24, S41-S49.
39. Tuziuti T, Yasui K, Sivakumar M, Iida Y, Miyoshi N. Correlation between cavitation noise and yield enhancement of sonochemical reaction by particle addition. J. Phys. Chem. A 2005, 109, 4869-4872.
40. Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 2008, 60, 1307-1315.
41. 2 in melanoma tumors. J. Control. Release 2011, 149, 190-195.
42. 2 bioconjugates and electroporation. Bioelectrochemistry 2007, 71, 217-222.
43. Chihara Y, Fujimoto K, Kondo H, Moriwaka Y, Sasahira T, Hirao Y, Kuniyasu H. Anti-tumor effects of liposomeencapsulated titanium dioxide in nude mice. Pathobiology 2007, 74, 353-358.
44. Yamaguchi S, Kobayashi H, Narita T, Kanehira K, Sonezaki S, Kudo N, Kubota Y, Terasaka S, Houkin K. Sonodynamic therapy using water-dispersed TiO2 -polyethylene glycol compound on glioma cells: comparison of cytotoxic mechanism with photodynamic therapy. Ultrason. Sonochem. 2011, 18, 1197-1204.
45. Sarin H, Kanevsky AS, Wu H, Brimacombe KR, Fung SH, Sousa AA, Auh S, Wilson CM, Sharma K, Aronova MA, Leapman RD, Griffiths GL, Hall MD. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J. Transl. Med. 2008, 6, 80-94.
46. Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 2009, 8, 331-336.
47. Osminkina LA, Gongalsky MB, Motuzuk AV, Timoshenko VY, Kudryavtsev AA. Silicon nanocrystals as photo- and sonosensitizers for biomedical applications. Appl. Phys. B 2011, 105, 665-668.
48. Weissleder R. Molecular imaging in cancer. Science 2006, 26, 1168-1171.
49. Lindner JR. Evolving applications for contrast ultrasound. Am. J. Cardiol. 2002, 90, 72-80.
50. Debbage P, Jaschke W. Molecular imaging with nanoparticles: giant roles for dwarf actors Histochem. Cell Biol. 2008, 130, 845-875.
51. Staley J, Grogan P, Samadi AK, Cui H, Cohen MS, Yang X. Growth of melanoma brain tumors monitored by photoacoustic microscopy. J. Biomed. Opt. 2010, 15, 40510-40513.
52. Siphanto RI, Thumma KK, Kolkman RG, van Leeuwen TG, de Mul FF, van Neck JW, van Adrichem LN, Steenbergen W. Serial noninvasive photoacoustic imaging of neovascularization in tumor angiogenesis. Opt. Express 2005, 13, 89-95.
53. Lao Y, Xing D, Yang S, Xiang L. Noninvasive photoacoustic imaging of the developing vasculature during early tumor growth. Phys. Med. Biol. 2008, 53, 4203-4212.
54. Ku G, Wang X, Xie X, Stoica G, Wang LV. Imaging of tumor angiogenesis in rat brains in vivo by photoacoustic tomography. Appl. Opt. 2005, 44, 770-775.
55. Lungu GF, Li ML, Xie X, Wang LV, Stoica G. In vivo imaging and characterization of hypoxia induced neovascularization and tumor invasion. Int. J. Oncol. 2007, 30, 45-54.
56. Li ML, Oh JT, Xie XY, Ku G, Wang W, Li C, Lungu G, Stoica G, Wang LV. Simultaneous molecular and hypoxia imaging of brain tumors in vivo using spectroscopic photoacoustic tomography. IEEE Int. Ultrason. Symp. 2008, 96, 481-489.
57. Zharov VP, Galanzha EI, Shashkov EV, Khlebtsov NG, Tuchin VV. In vivo photoacoustic flow cytometry for monitoring of circulating single cancer cells and contrast agents. Opt. Lett. 2006, 31, 3623-3625.
58. Weight RM, Viator JA, Dale PS, Caldwell CW, Lisle AE. Photoacoustic detection of metastatic melanoma cells in the human circulatory system. Opt. Lett. 2006, 31, 2998-3000.
59. Mallidi S, Luke GP, Emelianov S. Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. Trends Biotechnol. 2011, 29, 213-221.
60. Louie A. Multimodality imaging probes: design and challenges. Chem. Rev. 2010, 110, 3146-3195.
61. Razansky D, Vinegoni C, Ntziachristos V. Multispectral photoacoustic imaging of fluorochromes in small animals. Opt. Lett. 2007, 32, 2891-2893.
62. Kim G, Huang SW, Day KC, O'Donnell M, Agayan RR, Day MA, Kopelman R, Ashkenazi S. Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging. J. Biomed. Opt. 2007, 12, 044020.
63. Bouchard LS, Anwar MS, Liu GL, Hann B, Xie ZH, Gray JW, Wang X, Pines A, Chen FF. Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles. Proc. Natl. Acad. Sci. USA 2009, 106, 4085-4089.
64. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 2009, 38, 1759-1782.
65. Homan K, Shah J, Gomez S, Gensler H, Karpiouk A, Brannon- Peppas L, Emelianov S. Silver nanosystems for photoacoustic imaging and image-guided therapy. J. Biomed. Opt. 2010, 15, 021316.
66. You J, Shao R, Wei X, Gupta S, Li C. Near-infrared light triggers release of paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity. Small 2010, 6, 1022-1031.
67. Sazgarnia A, Shanei A, Meibodi NT, Eshghi H, Nassirli H. A novel nanosonosensitizer for sonodynamic therapy: in vivo study on a colon tumor model. J. Ultrasound Med. 2011, 30, 1321-1329.
68. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004, 11, 169-183.
69. Yang SJ, Lin FH, Tsai KC, Wei MF, Tsai HM, Wong JM, Shieh MJ. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjug. Chem. 2010, 21, 679-689.
70. Wang S, Gao R, Zhou F, Selke M. Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. J. Mater. Chem. 2004, 14, 487-493.
71. Perez JLJ, Orea AC, Gallegos ER, Fuentes RG. Photoacoustic spectroscopy to determine in vitro the nonradiative relaxation time of porotoporphyrin IX solution containing gold metallic nanoparticles. Eur. Phys. J. Spec. Top. 2008, 152, 353-356.
72. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4, 26-49.
73. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751-760.
74. Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, Chan WC, Cao W, Wang LV, Zheng G. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agent. Nat. Mater. 2011, 10, 324-332.
75. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2003, 2, 214-221.
76. Galanzha EI, Shashkov EV, Kelly T, Kim JW, Yang L, Zharov VP. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat. Nanotechnol. 2009, 4, 855-860.
77. Galanzha EI, Kokoska MS, Shashkov EV, Kim JW, Tuchin VV, Zharov VP. In vivo fibre-based multicolour photoacoustic detection and photothermal purging of metastasis in sentinel lymph nodes targeted by nanoparticles. J. Biophoton. 2009, 2, 528-539.